Presentation TCT 2015 Device and Clinical Program Highlights: Micell Presenter: Pieter C. Smits, Philip M. Urban, Alexandra J. Lansky October 12, 2015
Presentation TCT 2015 Device and Clinical Program Highlights: Firehawk Presenter: Pieter C. Smits, Philip M. Urban, Bo Xu October 12, 2015
Presentation TCT 2015 Why Contemporary Durable Polymers Are Not Good Enough. Do Any of the Current Bioabsorbable Polymers Make the Grade? Presenter: Pieter C. Smits, Philip M. Urban, Renu Virmani October 12, 2015
Presentation TCT 2015 Stentys Self-Expanding Stent With a Durable Polymer Eluting Sirolimus: Extended 2-Year Clinical and OCT Results From APPOSITION IV Presenter: Fernando Alfonso, Juan F. Granada, Robert-Jan van Geuns October 12, 2015
Presentation TCT 2015 A New Durable-PolymerBased Cobalt Chromium Stent: Rationale for and Design Characteristics of the BioNIR Stent and Clinical Development Program Presenter: Fernando Alfonso, Juan F. Granada, Pieter C. Smits October 12, 2015
Presentation TCT 2015 Microengineered Grooved Stent Surfaces and Beyond: Technology Description and Preliminary Data Presenter: Fernando Alfonso, Juan F. Granada October 12, 2015
Presentation TCT 2015 Debate: Can Todays Metallic Stent Platforms, Delivery Systems, and Durable Polymers Be Meaningfully Improved? No, the Bench, Experimental, and Clinical Results Are So Good, We Probably Have Reached a Therapeutic Plateau! Presenter: Fernando Alfonso, Juan F. Granada, Lisette Okkels Jensen October 12, 2015
Presentation TCT 2015 Debate: Can Todays Metallic Stent Platforms, Delivery Systems, and Durable Polymers Be Meaningfully Improved? Yes, Made Thinner and More Flexible, With Optimally Designed Platforms and Enhanced Polymers There Is Still Room for Improvement! Presenter: Fernando Alfonso, Juan F. Granada, Elazer R. Edelman October 12, 2015
News Conference News TCT 2015 Second-Generation DES, DCB Both Strategies for Treating In-Stent Restenosis October 12, 2015
News Industry News Clinical Trial Demonstrates That A Bioresorbable Scaffold is Non-Inferior To A Drug-Eluting Stent In Chinese Patients With Coronary Artery Disease October 12, 2015
News Conference News TCT 2015 BIOSOLVE-II: Novel Absorbable Scaffold Safe, Effective October 12, 2015
News Industry News ABSORB III: Clinical Trial Demonstrates That A Bioresorbable Scaffold Is Non-Inferior To A Drug-Eluting Stent In Patients With Coronary Artery Disease October 12, 2015
Presentation TCT 2015 Case Presentation Before Second-Time Treatment: Recurrent DES Restenosis Presenter: Robert A. Byrne, Stefan K. James, Wojtek Wojakowski October 11, 2015
Presentation TCT 2015 The Resurrection of Historic Therapies for Refractory Restenosis: Vascular Brachytherapy, Atherectomy, and Beyond Presenter: Robert A. Byrne, Stefan K. James, Paul S. Teirstein October 11, 2015
Presentation TCT 2015 Drug-Eluting Stent Restenosis State of the Art: Causes, Evaluation, and Treatment Presenter: Robert A. Byrne, Stefan K. James, Fernando Alfonso October 11, 2015
Presentation TCT 2015 How Was the Case Treated Presenter: Robert A. Byrne, Stefan K. James, Ehrin J. Armstrong October 11, 2015
Presentation TCT 2015 Case Presentation Before Treatment: An Unexpected and Difficult to Treat Stent Thrombosis Presenter: Robert A. Byrne, Stefan K. James, Ehrin J. Armstrong October 11, 2015
Presentation TCT 2015 Are There Differences in the Outcomes of Early, Late, and Very Late Stent Thrombosis? Presenter: Robert A. Byrne, Stefan K. James, Donald Cutlip October 11, 2015
Presentation TCT 2015 New Insights Into Neoatherosclerosis as a Frequent Common Denominator of DES Failure Presenter: Robert A. Byrne, Stefan K. James, Renu Virmani October 11, 2015